Oops! It appears that you have disabled your Javascript. In order for you to see this page as it is meant to appear, we ask that you please re-enable your Javascript!

HOWARU® Restore II

HOWARU® Restore II

HOWARU® Restore II (L. acidophilus NCFM® and L. paracasei Lpc-37™, B. lactis Bi-07™ and B. lactis Bl-04®)

Restoring gut health and overcoming gut discomfort caused by antibiotics

The gut is the “second brain” of our body. It determines our health and affects our mood. Improper diet, fast-paced lifestyle, travel and treatment with antibiotics can all cause or aggravate irritable bowel syndrome (IBS) and damage our gut health.

HOWARU® Restore II is a probiotic formulation combining L. acidophilus NCFM® and L. paracasei Lpc-37™, B. lactis Bi-07™ and B. lactis Bl-04®. It has been proven to reduce the impact of AAD in patients undergoing antibiotic therapy. Its unique benefits are attributed to formulation, which is designed to provide 50% by count of those bacteria that are adapted to the upper intestine—specifically the Lactobacillus species: L. acidophilus NCFM® and L. paracasei Lpc-37™. The remaining 50% by count is provided by the Bifidobacterium species, which are adapted to the lower intestinal tract. These strains are B. lactis Bi-07™ and B. lactis Bl-04®.

HOWARU® Restore II has been widely used in dietary supplements such as capsules, tablets and powders, as well as yogurt, freshly fermented or unfermented milk, chocolate candies or nutritional bars.

HOWARU® Restore II is proven to help restore gut health.

Ouwehand conducted a triple-blind, randomized, placebo-controlled trial on 503 adults recruited by Shanghai Changhai Hospital. The study showed that the tested four-strain probiotic combination (i.e. HOWARU® Restore II) appears to lower the risk of AAD, CDAD and gastrointestinal symptoms in a dose-dependent manner in adult in-patients. This clinical trial is the largest one to investigate the incidence of AAD on the dose of probiotics, and also the only study on the incidence of AAD and CDAD symptoms in adult in-patients requiring antibiotic therapy.

Key findings for HOWARU® Restore II:

  • Significantly reduced incidences of diarrhea by 50%
  • Significantly reduced duration of diarrhea by 52%
  • Significantly reduced gastrointestinal symptoms such as abdominal cramp and bloating caused by antibiotics treatment

Why choose HOWARU® Restore II?

  • A clinically documented product enhancing gut health
  • Offered in consumer-ready finished formats, easy to take
  • Probiotics with stabilization technology